2m 2m 2m 2m 2m 2m 2m
ENGENE THERAP (ENGN)
NASDAQ
$1.70+$0.01 (+0.59%)
Price as of Jun 23, 2026 6:13 PM EDT- $113.2MMarket Cap
- -44.04%1-Year Change
- BiotechnologyIndustry
ENGENE THERAP (ENGN)
$1.70+$0.01 (+0.59%)
ENGN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.69 | ||
Change | -$0.03 (-1.74%) | ||
Open | $1.74 | ||
High | $1.76 | ||
Low | $1.69 | ||
Previous Close | $1.72 | ||
Volume | 883,240 | ||
30-Day Average Volume | 992,168 | ||
1-Week Change | -4.52% | ||
1-Month Change | 3.05% | ||
1-Year Change | -44.04% | ||
3-Year Change | -96.55% | ||
5-Year Change | -96.55% | ||
Fundamentals | |||
Shares Outstanding | 67.0M | ||
Total Assets | $307.5M | ||
Market Cap | $113.2M | ||
Enterprise Value | $108.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$30.2M | ||
Free Cash Flow | -$30.6M | ||
EBIT | -$29.5M | ||
EBITDA | -$29.3M | ||
Net Working Capital | $248.5M | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | 08/03/2015 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue